The effect of milk components, especially of casein, on the bioavailability of ciprofloxacin tablets cannot be evaluated by dissolution testing

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 3, 2010, Pages 819-820

  Simon, Žakelj ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bioavailability; Ciprofloxacin; Dissolution; Fluoroquinolone; Interaction; Milk

Indexed keywords

CALCIUM; CASEIN; CIPROFLOXACIN; NORFLOXACIN;

ANTIBIOTIC RESISTANCE; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG SOLUBILITY; HUMAN; LETTER; MILK; NONHUMAN; PH; PRIORITY JOURNAL; TABLET;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOLOGICAL AVAILABILITY; CASEINS; CATTLE; CIPROFLOXACIN; FOOD-DRUG INTERACTIONS; MILK; SOLUBILITY; TABLETS;

EID: 77954863199     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.04.016     Document Type: Letter

References (17)

1. K. Pápai, M. Budai, K. Ludányi, I. Antal, I. Klebovich, In vitro food-drug interaction study: which milk component has a decreasing effect on the bioavailability of ciprofloxacin? J. Pharm. Biomed. Anal. 52 (2010) 37-42.
2. G. Höffken, K. Borner, P.D. Glatzel, P. Koeppe, H. Lode, Reduced enteral absorption of ciprofloxacin in the presence of antacids, Eur. J. Clin. Microbiol. 4 (1985) 345.
3. G.L. Amidon, H. Lennernäs, V.P. Shah, J.R. Crison, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res. 12 (1995) 413-420.
4. S.C. Wallis, B.G. Charles, L.R. Gahan, L.J. Filippich, M.G. Bredhauer, P.A. Duckworth, Interaction of norfloxacin with divalent and trivalent pharmaceutical cations. In vitro complexation and in vivo pharmacokinetic studies in the dog, J. Pharm. Sci. 85 (1996) 803-809.
5. B.M. Lomaestro, G.R. Bailie, Absorption interactions with fluoroquinolones. 1995 update, Drug Saf. 12 (1995) 314-333
6. K. Pápai, M. Budai, K. Ludányi, I. Antal, I. Klebovich, In vitro food-drug interaction study: which milk component has a decreasing effect on the bioavailability of ciprofloxacin? J. Pharm. Biomed. Anal. 52 (2010) 37-42.
7. J.B. Dressman, G.L. Amidon, C. Reppas, V.P. Shah, Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms, Pharm. Res. 15 (1998) 11-22.
8. S. Al-Behaisi, I. Antal, Gy. Morovján, S. Marton, I. Klebovich, Study of the acidbuffering capacity of dietary components regarding food-druginteractions, Acta Pharm. Hung. 72 (2002) 185-190.
9. G.L. Amidon, H. Lennernas, V.P. Shah, J.R. Crison, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res. 12 (1995) 413-420.
10. C.Y. Wu, L. Benet, Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system, Pharm. Res. 22 (2005) 11-23.
11. G.L. Amidon, H. Lennernas, V.P. Shah, J.R. Crison, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res. 12 (1995) 413-419.
12. P.J. Neuvonen, K.T. Kivistö, P. Lehto, Interference of dairy products with the absorption of ciprofloxacin, Clin. Pharmacol. Ther. 50 (1991) 498-502.
13. Y. Boirie, M. Dangin, P. Gachon, M.P. Vasson, J.L. Maubois, B. Beaufrere, Slow and fast dietary proteins differently modulate postprandial protein accretion, Proc. Natl. Acad. Sci. USA 94 (1997) 14930-14935.
14. J. Sahai, D.P. Healy, J. Stotka, R. Polk, The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin, Br. J. Clin. Pharmacol. 35 (1993) 302-304.
15. G. Höffken, H. Lode, R. Wiley, T.D. Glatzel, D. Sievers, T. Olschewski, K. Borner, T. Koeppe, Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effect of food and antacid intake, Rev. Infect. Dis. 10 (1988) 138-139.
16. J.D. Frost, A.J. Carlson, A. Dietz, J.T. Heyd, Ciprofloxacin pharmacokinetics after a standard or high fat/high calcium breakfast, J. Clin. Pharmacol. 29 (1989) 953-955.
17. A. Shah, M.C. Liu, D. Vaughan, A.H. Heller, Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension, J. Antimicrob. Chemother. 43 (1999) 49-54.